Incidence of extraarticular rheumatoid arthritis in olmsted county, Minnesota, in 1995-2007 versus 1985-1994: A population-based study

Journal of Rheumatology

Volumn 38, Issue 6, 2011, Pages 983-989

  Myasoedova, Elena ^a   Crowson, Cynthia S ^a   Turesson, Carl ^a   Gabriel, Sherine E ^a,b   Matteson, Eric L ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Mayo Clinic   (United States)

Author keywords

Extraarticular manifestations; Incidence; Mortality; Rheumatoid arthritis; Risk factors

Indexed keywords

CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; HYDROXYCHLOROQUINE; METHOTREXATE; RHEUMATOID FACTOR;

ADULT; ARTICLE; BONE EROSION; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; EXTRAARTICULAR RHEUMATOID ARTHRITIS; FEMALE; HUMAN; INCIDENCE; JOINT DESTRUCTION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RHEUMATOID NODULE; RHEUMATOID VASCULITIS; RISK FACTOR; SEX DIFFERENCE; UNITED STATES;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COMORBIDITY; FEMALE; GEOGRAPHY; HUMANS; INCIDENCE; MALE; METHOTREXATE; MIDDLE AGED; MINNESOTA; POPULATION GROUPS; RETROSPECTIVE STUDIES; RHEUMATOID FACTOR; RHEUMATOID VASCULITIS;

EID: 79957859112     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.101133     Document Type: Article

References (31)

1. Calguneri M, Ureten K, Akif Ozturk M, Onat AM, Ertenli I, Kiraz S, et al. Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol 2006;24:305-8. (Pubitemid 44151151)
2. Carmona L, Gonzalez-Alvaro I, Balsa A, Angel Belmonte M, Tena X, Sanmarti R. Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis 2003;62:897-900. (Pubitemid 37026504)
3. Cimmino MA, Salvarani C, Macchioni P, Montecucco C, Fossaluzza V, Mascia MT, et al. Extra-articular manifestations in 587 Italian patients with rheumatoid arthritis. Rheumatol Int 2000;19:213-7.
4. Gabriel SE, Crowson CS, Kremers HM, Doran MF, Turesson C, O'Fallon WM, et al. Survival in rheumatoid arthritis: a population-based analysis of trends over 40 years. Arthritis Rheum 2003;48:54-8. (Pubitemid 36091647)
5. Turesson C, Jacobsson L, Bergstrom U. Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology 1999;38:668-74. (Pubitemid 29507338)
6. Turesson C, Jarenros A, Jacobsson L. Increased incidence of cardiovascular disease in patients with rheumatoid arthritis: results from a community based study. Ann Rheum Dis 2004;63:952-5. (Pubitemid 38961920)
7. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62-7. (Pubitemid 34041860)
8. Odegard S, Kvien TK, Uhlig T. Incidence of clinically important 10-year health status and disease activity levels in population-based cohorts with rheumatoid arthritis. J Rheumatol 2008;35:54-60.
9. Pincus T, Sokka T, Kautiainen H. Patients seen for standard rheumatoid arthritis care have significantly better articular, radiographic, laboratory, and functional status in 2000 than in 1985. Arthritis Rheum 2005;52:1009-19.
10. Tanaka E, Mannalithara A, Inoue E, Hara M, Tomatsu T, Kamatani N, et al. Efficient management of rheumatoid arthritis significantly reduces long-term functional disability. Ann Rheum Dis 2008;67:1153-8.
11. Welsing PM, Fransen J, van Riel PL. Is the disease course of rheumatoid arthritis becoming milder? Time trends since 1985 in an inception cohort of early rheumatoid arthritis. Arthritis Rheum 2005;52:2616-24.
12. Turesson C, McClelland RL, Christianson TJ, Matteson EL. No decrease over time in the incidence of vasculitis or other extraarticular manifestations in rheumatoid arthritis: results from a community-based study. Arthritis Rheum 2004;50:3729-31. (Pubitemid 39488703)
13. Turesson C, O'Fallon WM, Crowson CS, Gabriel SE, Matteson EL. Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years. Ann Rheum Dis 2003;62:722-7. (Pubitemid 36886405)
14. Maradit Kremers H, Crowson CS, Gabriel SE. Rochester Epidemiology Project: a unique resource for research in the rheumatic diseases. Rheum Dis Clin North Am 2004;30:819-34, vii.
15. Melton LJ 3rd. History of the Rochester Epidemiology Project. Mayo Clin Proc 1996;71:266-74.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
17. Aalen O. Nonparametric estimation of partial transition probabilities in multiple decrement models. Ann Stat 1978;6:534-5.
18. Kalbfleisch JD, Prentice RL. The statistical analysis of failure time data. New York: Wiley; 2002.
19. Gray R. A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988;16:1141-54.
20. Ward MM. Decreases in rates of hospitalizations for manifestations of severe rheumatoid arthritis, 1983-2001. Arthritis Rheum 2004;50:1122-31.
21. Watts RA, Mooney J, Lane SE, Scott DG. Rheumatoid vasculitis: becoming extinct? Rheumatology 2004;43:920-3.
22. Bartels CM, Bell CL, Shinki K, Rosenthal A, Bridges AJ. Changing trends in serious extra-articular manifestations of rheumatoid arthritis among United State veterans over 20 years. Rheumatology 2010;49:1670-5.
23. Hellmann M, Jung N, Owczarczyk K, Hallek M, Rubbert A. Successful treatment of rheumatoid vasculitis-associated cutaneous ulcers using rituximab in two patients with rheumatoid arthritis. Rheumatology 2008;47:929-30. (Pubitemid 351796389)
24. Puechal X, Miceli-Richard C, Mejjad O, Lafforgue P, Marcelli C, Solau-Gervais E, et al. Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis. Ann Rheum Dis 2008;67:880-4. (Pubitemid 351829393)
25. Wolfe F, Caplan L, Michaud K. Rheumatoid arthritis treatment and the risk of severe interstitial lung disease. Scand J Rheumatol 2007;36:172-8. (Pubitemid 47174545)
26. Lindsay K, Melsom R, Jacob BK, Mestry N. Acute progression of interstitial lung disease: a complication of etanercept particularly in the presence of rheumatoid lung and methotrexate treatment. Rheumatology 2006;45:1048-9. (Pubitemid 44283069)
27. Williams FM, Cohen PR, Arnett FC. Accelerated cutaneous nodulosis during methotrexate therapy in a patient with rheumatoid arthritis. J Am Acad Dermatol 1998;39:359-62. (Pubitemid 28367316)
28. Turesson C, Eberhardt K, Jacobsson LT, Lindqvist E. Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort. Ann Rheum Dis 2007;66:1543-4. (Pubitemid 350032670)
29. Nyhall-Wahlin BM, Petersson IF, Nilsson JA, Jacobsson LT, Turesson C. High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis. Rheumatology 2009;48:416-20.
30. Erhardt CC, Mumford PA, Venables PJ, Maini RN. Factors predicting a poor life prognosis in rheumatoid arthritis: an eight year prospective study. Ann Rheum Dis 1989;48:7-13. (Pubitemid 19022787)
31. Myasoedova E, Crowson CS, Kremers HM, Therneau TM, Gabriel SE. Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010;62:1576-82.